Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

The George Washington University

Headquarters: Washington, DC, United States of America
Year Founded: 1821
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Oct 21, 2022
Discovery & Translation

Oncorus’ synthetic RNA viruses for immunotherapy; plus Sisu’s small molecule for AML and more

BioCentury’s roundup of translational news
BioCentury | May 8, 2021
Targets & Mechanisms

Long COVID’s big tent needs to get more precise

Breaking the disease into subtypes will be important for getting more companies into the space
BioCentury | Jan 1, 2021
Targets & Mechanisms

A snapshot of target innovation in 2020

An analysis of BioCentury’s Distillery captures trends from preclinical publications in 2020
BioCentury | Aug 27, 2020
Distillery Therapeutics

Antisense oligos against transcription factor DUX4 for a muscular dystrophy

DISEASE CATEGORY: Musculoskeletal
INDICATION: Muscular dystrophy Antisense oligonucleotide therapies targeting DUX4 could treat facioscapulohumeral muscular dystrophy (FSHD), which is caused by
BioCentury | Feb 28, 2019
Translation in Brief

Damming up metastasis

How platelet ‘decoys’ could prevent cancer metastasis
BioCentury | Feb 28, 2019
Distillery Therapeutics

Cancer; hematology

BioCentury | Jan 4, 2018
Strategy

Next generation resolutions

Charting FDA’s recent progress and ongoing campaigns in NGS diagnostics
BioCentury | Aug 16, 2017
Distillery Techniques

Biomarkers

BioCentury | Jul 11, 2017
Preclinical News

Amino acid transporter linked to depression

BioCentury | Apr 13, 2017
Targets & Mechanisms

Cool and also collected

Thymosin α1 may be a rare one-stop shop for cystic fibrosis
Items per page:
1 - 10 of 34